These authors utilized the novel CXCR4 inhibitor Peptide R for therapeutic purposes, which decreased cancer cells’ metastatic potential by impairing the crosstalk between tumor cells and normal stem cells [80]. The gene discussed is CXCR4; the disease is neoplasm.